Patient-reported outcomes following platelet-rich plasma (PRP) compared to corticosteroid intra-articular injection for treatment of adhesive capsulitis: A randomised controlled trial

Dr Matthew Brick0 个研究点目标入组 200 人开始时间: 2022年4月26日最近更新: 2022年5月2日

适应症

试验速览

暂无简介。

•Patients aged 18 years or over living in Auckland region
•Specialist-confirmed diagnosis of adhesive capsulitis
•Shoulder pain and restricted range of motion in shoulder
•Symptoms between 1-12 months
•Shoulder radiograph and ultrasound scan. Radiology will document capsular thickness, bursal thickness, prevalence of co-existing calcific tendonitis, rotator cuff tendinopathy/minor tear or joint effusion. These findings are not exclusion criteria.

•Serious orthopaedic or medical co-morbidity including osteoarthritis, fracture, dislocation, massive rotator cuff tear, infection, malignancy, haematological disorder, chronic regional pain syndrome of the shoulder, crystal arthropathy of shoulder confirmed on previous aspirate, previous shoulder injection within 3 months
•Participants need to avoid steroids and non-steroidal anti-inflammatories (NSAID) in the week prior and week after their injection. This will be screened for during the consent process and immediately before the procedure. Patients using these medications will be deferred to a later procedure day when they haven’t used them for over one week prior.

发起方

Dr Matthew Brick